Australia-based nutraceuticals maker Creso Pharma signed a letter to enter a distribution deal with ImpACTIVE Holdings Ltd, Canada. ImpACTIVE is to distribute Creso’s suite of hemp CBD based human health products, CannaDOL and cannaQIX, in Canada and the U.S., while Creso is to distribute ImpACTIVE’s CBD based roll-on product in Switzerland and Europe if the deal is consummated. ImpACTIVE is a Canadian company founded by a group of athletes that sells a range of CBD products for muscle and joint inflammation. Creso said it has access to over 2,100 pharmacies and 400 sport and fitness centers in Switzerland alone.
Like HempToday? How you can support us
Your donations help us to keep HempToday open for all readers, regardless of what they can afford to pay. Through this “information equality” we're able to support hemp entrepreneurs and stakeholders all over the world by keeping a spotlight on hemp and all the promise it offers for economic development and healing our planet.